These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10843535)
1. HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1. Clatts MC; Heimer R; Abdala N; Goldsamt LA; Sotheran JL; Anderson KT; Gallo TM; Hoffer LD; Luciano PA; Kyriakides T J Acquir Immune Defic Syndr; 1999 Oct; 22(2):194-9. PubMed ID: 10843535 [TBL] [Abstract][Full Text] [Related]
2. Detection of HIV-1 in injection paraphernalia: risk in an era of heightened awareness. Page JB; Shapshak P; Duran EM; Even G; Moleon-Borodowski I; Llanusa-Cestero R AIDS Patient Care STDS; 2006 Aug; 20(8):576-85. PubMed ID: 16893327 [TBL] [Abstract][Full Text] [Related]
3. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. Shah SM; Shapshak P; Rivers JE; Stewart RV; Weatherby NL; Xin KQ; Page JB; Chitwood DD; Mash DC; Vlahov D; McCoy CB J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar; 11(3):301-6. PubMed ID: 8603266 [TBL] [Abstract][Full Text] [Related]
4. Recovery of Infectious Hepatitis C Virus From Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs. Heimer R; Binka M; Koester S; Grund JC; Patel A; Paintsil E; Lindenbach BD J Infect Dis; 2018 Jan; 217(3):466-473. PubMed ID: 28968665 [TBL] [Abstract][Full Text] [Related]
5. Explaining the geographical variation of HIV among injection drug users in the United States. Ciccarone D; Bourgois P Subst Use Misuse; 2003 Dec; 38(14):2049-63. PubMed ID: 14677781 [TBL] [Abstract][Full Text] [Related]
6. Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water. McCoy CB; Metsch LR; Chitwood DD; Shapshak P; Comerford ST J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S25-9. PubMed ID: 9663620 [TBL] [Abstract][Full Text] [Related]
7. HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Needle RH; Coyle S; Cesari H; Trotter R; Clatts M; Koester S; Price L; McLellan E; Finlinson A; Bluthenthal RN; Pierce T; Johnson J; Jones TS; Williams M Subst Use Misuse; 1998 Oct; 33(12):2403-23. PubMed ID: 9781822 [TBL] [Abstract][Full Text] [Related]
8. Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users. Abdala N; Gleghorn AA; Carney JM; Heimer R J Acquir Immune Defic Syndr; 2001 Dec; 28(5):487-94. PubMed ID: 11744839 [TBL] [Abstract][Full Text] [Related]
9. Changes in Reported Injection Behaviors Following the Public Health Response to an HIV Outbreak Among People Who Inject Drugs: Indiana, 2016. Dasgupta S; Broz D; Tanner M; Patel M; Halleck B; Peters PJ; Weidle PJ; O'Donnell J; Amlung J; McAlister C; Chapman E; Bailey A; Burnett J; Duwve J AIDS Behav; 2019 Dec; 23(12):3257-3266. PubMed ID: 31313095 [TBL] [Abstract][Full Text] [Related]
10. Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated With Sharing Equipment. Ball LJ; Venner C; Tirona RG; Arts E; Gupta K; Wiener JC; Koivu S; Silverman MS J Acquir Immune Defic Syndr; 2019 Aug; 81(4):e127-e134. PubMed ID: 31021987 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis A virus survival on drug paraphernalia. Medrzycki M; Kamili S; Purdy MA J Viral Hepat; 2020 Dec; 27(12):1484-1494. PubMed ID: 32810349 [TBL] [Abstract][Full Text] [Related]
12. Contamination of medicine injection paraphernalia used by registered medical practitioners in south India: an ethnographic study. Lakshman M; Nichter M Soc Sci Med; 2000 Jul; 51(1):11-28. PubMed ID: 10817465 [TBL] [Abstract][Full Text] [Related]
13. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran. Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125 [TBL] [Abstract][Full Text] [Related]
14. Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999). Thorpe LE; Bailey SL; Huo D; Monterroso ER; Ouellet LJ J Acquir Immune Defic Syndr; 2001 May; 27(1):71-8. PubMed ID: 11404523 [TBL] [Abstract][Full Text] [Related]
16. Effects of varying concentrations of bleach on in vitro HIV-1 replication and the relevance to injection drug use. Contoreggi C; Jones S; Simpson P; Lange WR; Meyer WA Intervirology; 2000; 43(1):1-5. PubMed ID: 10773730 [TBL] [Abstract][Full Text] [Related]
17. Using Pharmacies in a Structural Intervention to Distribute Low Dead Space Syringes to Reduce HIV and HCV Transmission in People Who Inject Drugs. Oramasionwu CU; Johnson TL; Zule WA; Carda-Auten J; Golin CE Am J Public Health; 2015 Jun; 105(6):1066-71. PubMed ID: 25880955 [TBL] [Abstract][Full Text] [Related]
18. Sharing spoons: a risk factor for HIV-1 infection in Vienna. Loimer N; Werner E; Presslich O Br J Addict; 1991 Jun; 86(6):775-8. PubMed ID: 1878627 [TBL] [Abstract][Full Text] [Related]
19. The effect of acids on the survival of HIV during drug injection. Heimer R; Kinzly ML; He H; Abdala N J Acquir Immune Defic Syndr; 2007 Jun; 45(2):144-50. PubMed ID: 17356472 [TBL] [Abstract][Full Text] [Related]
20. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing. Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]